Placental corticotropin releasing-hormone and urocortin - Possible role in mechanism of preterm labor;Łożyskowa kortykoliberyna i urokortyna - Przypuszczalna ich rola w wysta̧pieniu porodu przedwczesnego

Polski Merkuriusz Lekarski

Volumn 21, Issue 124, 2006, Pages 398-400

  Mȩczekalski, Błazej ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Corticotropin releasing hormone; Placenta; Preterm labor; Urocortin

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; CYTOKINE; GROWTH FACTOR; UROCORTIN; CORTICOTROPIN RELEASING FACTOR RECEPTOR;

AMNION; CHILDBIRTH; CHORION; CONTROLLED STUDY; HUMAN; MORBIDITY; MORTALITY; PLACENTA; PREMATURE LABOR; REVIEW; ANIMAL; FEMALE; GENETICS; METABOLISM; PHYSIOLOGY; PREGNANCY; PREGNANCY COMPLICATION; RAT;

ANIMALS; CORTICOTROPIN-RELEASING HORMONE; FEMALE; HUMANS; OBSTETRIC LABOR, PREMATURE; PLACENTA; PREGNANCY; PREGNANCY COMPLICATIONS; RATS; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE;

EID: 33751047586     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (35)

1. Barbieri R.L.: The maternal adenophysis. In: Tulchinsky D.: Little Abeds Maternal-fetal endocrinology. W.B. Saunders, Philadephia 1994.
2. Chan E.G., Brinsmead M.W., Chen S.E. i wsp.: corticotropin-releasing hormone immunoreactivity is elevated during human pregnancy. Gynecol. Endocrinol., 1990, 4(4), 233-244.
3. Chen R., Lewis K.A., Perrin M.H. i wsp.: Expression cloning of a human corticotropin-releasing-factor receptor. Proc. Natl. Acad. Sci. USA, 1993, 90(19), 8967-8971.
4. Challis J.R., Lye S.J., Gibb W. i wsp.: Understanding preterm labor. Ann. NY Acad. Sci., 2001, 943, 225-234.
5. Clifton V.L., Gu Q., Murphy V.E. i wsp.: Localization and characterization of urocortin during human pregnancy. Placenta, 2000, 21(8), 782-788.
6. Donaldson C.J., Sutton S.W., Perrin M.H. i wsp.: Cloning and characterization of human urocortin. Endocrinology, 1996, 137(9), 3896-3899.
7. Fadalti M., Pezzani I., Cobellis L. i wsp.: Placental corticotropin-releasing factor. An update. Ann. NY Acad. Sci., 2000, 900, 89-94.
8. Florio P., Cobellis L., Woodman J. i wsp.: Levels of maternal plasma corticotropin-releasing factor and urocortin during labor. J. Soc. Gynecol. Investig., 2002, 9(4), 233-237.
9. Florio P., Torricelli M., Galleri L. i wsp.: High fetal urocortin levels at term and preterm labor. J. Clin. Endocrinol. Metab., 2005, 90(9), 5361-5365.
10. Florio F., Vale W., Petraglia F.: Urocortins in human reproduction. Peptides, 2004, 25, 1751-1758.
11. Hsu S.Y., Hsueh A.J.: Human stresscopin and stresscopin-related peptide are selective ligands for the type 2 corticotropin-releasing hormone receptor. Nat. Med., 2001, 7(5), 605-611.
12. Inder W.J., Prickelt T.C. , Ellis M.J. i wsp.: The utility of plasma CRH as a predictor of preterm delivery. J. Clin. Endocrinol. Metab., 2001, 86(12), 5706-5710.
13. Jackson M., Dudlez D.J.: Endocrine assays to predict preterm delivery. Clinics in Perinatol, 1998, 25, 837-857.
14. Keck M.E., Ohl F., Holsboer F. i wsp.: Listening to mutant mice: a spotlight on the role of CRF/CRF receptor systems in affective disorders. Neurosci. Biobehav. Rev., 2005, 29(4-5), 867-889.
15. Linton E.A., Wolfe C.D., Behan D.P. i wsp.: A specific carrier substance for human corticotrophin releasing factor in late gestational maternal plasma which could mask the ACTH-releasing activity. Clin. Endocrinol. (Oxf.), 1988, 28(3), 315-324.
16. Makrigiannakis A., Zoumakis E., Kalantaridou S. i wsp.: Corticotropin-releasing hormone (CRH) and immunotolerance of the fetus. Biochem. Pharmacol., 2003, 65(6), 917-921.
17. McLean M., Bisits A., Davies J.: A placental clock controlling the length of human pregnancy. Nat. Med., 1995, 1, 460-463.
18. McLean M., Smith R.: Corticotropin-releasing hormone and human parturition. Reproduction., 2001, 121, 493-501.
19. Ochedalski T., Lachowicz A.: Maternal and fetal hypothalamo-pituitary- adrenal axis: different response depends upon the mode of parturition. Neuro. Endocrinol. Lett., 2004, 25(4), 278-282.
20. Petraglia F., Florio P., Benedetto C. i wsp.: Urocortin stimulates placental adrenocorticotropin and prostag/andin release and myometrial contractility in vitro. J. Clin. Endocrinol. Metab., 1999, 84(4), 1420-1423.
21. Petraglia F., Florio P., Nappi C. i wsp.: Peptide signaling in human placenta and membranes: autocrine, paracrine, and endocrine mechanisms. Endocr. Rev., 1996, 17, 156-186.
22. Petraglia F., Genazzani A.D., Aguzzoli L. i wsp.: Pulsatile fluctuations of plasma gonadotropin-releasing hormone and corticotropin-releasing factor levels in healthy pregnant women. Acta Obstet. Gynecol. Scand., 1994, 73(4), 284-289.
23. Petraglia F., Potter E., Cameron V.A. i wsp.: Corticotropin-releasing factor-binding protein is produced by human placenta and intrauterine tissues. J. Clin. Endocrinol. Metab., 1993, 77(4), 919-924.
24. Petraglia F., Sutton S., Vale W.: Neurotransmitters and peptides modulate the release of immunoreactive corticotropin-releasing factor from cultured human placental cells. Am. J. Obstet. Gynecol., 1989, 160(1), 247-251.
25. Potter E., Behan D.P., Fischer W.H. i wsp.: Cloning and characterization of the cDNAs for human and rat corticotropin releasing factor-binding proteins. Nature, 1991, 349(6308), 423-426.
26. Reis F.M., Faldati M., Florio P. i wsp.: Putative role of placental corticotropin-releasing factor in the mechanisms of human parturition. J. Soc. Gynecol. Investig., 1999, 6(3), 109-119.
27. Rivier C., Vale W.: Modulation of stress-induced ACTH release by corticotropin-releasing factor, catecholamines and vasopressin. Nature, 1983, 305(5932), 325-327.
28. Shibasaki T., Odagiri E., Shizume K. i wsp.: Corticotropin-releasing factor-like activity in human placental extracts. J. Clin. Endocrinol. Metab., 1982, 55, 384-386.
29. Sibai B., Meis P.J., Klebanoff M. i wsp.: Plasma CRH measurement at 16 to 20 weeks' gestation does not predict preterm delivery in women at high-risk for preterm delivery. Am. J. Obstet. Gynecol., 2005, 193(3 Pt 2), 1181-1186.
30. Sirianni R., Mayhew B.A., Carr B.R. i wsp.: Corticotropin-releasing hormone (CRH) and urocortin act through type 1 CRH receptors to stimulate dehydroepiandrosterone sulfate production in human fetal adrenal cells. J. Clin. Endocrinol. Metab., 2005, 90(9), 5393-5400.
31. Smith R.: The timing of the birth. Sci. Am., 1999, 280, 68-75.
32. Smith R., Mesiano S., McGrath S.: Hormone trajectories leading to human birth. Regul. Pept., 2002, 108(2-3), 159-164.
33. Suda T., Tomori N., Tozawa F. i wsp.: Distribution and characterization of immunoreactive corticotropin-releasing factor in human tissues. J. Clin. Endocrinol. Metab., 1984, 59, 861-866.
34. Torricelli M., Ignacchiti E., Giovanelli A. i wsp.: Maternal plasma corticotrophin-releasing factor and urocortin levels in post-term pregnancies. Eur. J. Endocrinol., 2006, 154(2), 281-285.
35. Vogel I., Thorsen P., Curry A. i wsp.: Biomarkers for the prediction of preterm delivery. Acta Obstet. Gynecol. Scand., 2005, 84(6), 516-525.